Search icon

ANTARES PHARMA, INC.

Company Details

Name: ANTARES PHARMA, INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Active
Date of registration: 04 Feb 2016 (9 years ago)
Entity Number: 4890787
ZIP code: 10005
County: New York
Place of Formation: Delaware
Address: 28 LIBERTY ST., NEW YORK, NY, United States, 10005
Principal Address: 100 PRINCETON SOUTH, SUITE 300, EWING, NJ, United States, 08628

Agent

Name Role Address
C T CORPORATION SYSTEM Agent 28 LIBERTY ST., NEW YORK, NY, 10005

DOS Process Agent

Name Role Address
ANTARES PHARMA, INC. DOS Process Agent 28 LIBERTY ST., NEW YORK, NY, United States, 10005

Chief Executive Officer

Name Role Address
HELEN TORLEY Chief Executive Officer 100 PRINCETON SOUTH, SUITE 300, EWING, NJ, United States, 08628

History

Start date End date Type Value
2024-03-01 2024-03-01 Address 100 PRINCETON SOUTH, SUITE 300, EWING, NJ, 08628, USA (Type of address: Chief Executive Officer)
2020-02-03 2024-03-01 Address 28 LIBERTY ST., NEW YORK, NY, 10005, USA (Type of address: Service of Process)
2019-01-28 2024-03-01 Address 28 LIBERTY ST., NEW YORK, NY, 10005, USA (Type of address: Registered Agent)
2019-01-28 2020-02-03 Address 28 LIBERTY ST., NEW YORK, NY, 10005, USA (Type of address: Service of Process)
2018-02-01 2024-03-01 Address 100 PRINCETON SOUTH, SUITE 300, EWING, NJ, 08628, USA (Type of address: Chief Executive Officer)
2016-02-04 2019-01-28 Address 111 EIGHTH AVENUE, NEW YORK, NY, 10011, USA (Type of address: Service of Process)
2016-02-04 2019-01-28 Address 111 EIGHTH AVENUE, NEW YORK, NY, 10011, USA (Type of address: Registered Agent)

Filings

Filing Number Date Filed Type Effective Date
240301051689 2024-03-01 BIENNIAL STATEMENT 2024-03-01
220201001271 2022-02-01 BIENNIAL STATEMENT 2022-02-01
200203060092 2020-02-03 BIENNIAL STATEMENT 2020-02-01
SR-74397 2019-01-28 CERTIFICATE OF CHANGE (BY AGENT) 2019-01-28
SR-74396 2019-01-28 CERTIFICATE OF CHANGE (BY AGENT) 2019-01-28
180201006758 2018-02-01 BIENNIAL STATEMENT 2018-02-01
160204000129 2016-02-04 APPLICATION OF AUTHORITY 2016-02-04

Court Cases

Docket Number Nature of Suit Filing Date Disposition
2203782 Securities, Commodities, Exchange 2022-05-10 voluntarily
Circuit Second Circuit
Origin original proceeding
Jurisdiction federal question
Jury Demand Neither plaintiff nor defendant demands jury
Demanded Amount 0
Termination Class Action Missing
Procedural Progress no court action
Nature Of Judgment no monetary award
Judgement missing
Arbitration On Termination Missing
Office 1
Filing Date 2022-05-10
Termination Date 2022-05-25
Section 0078
Status Terminated

Parties

Name FINGER
Role Plaintiff
Name ANTARES PHARMA, INC.
Role Defendant
2202725 Securities, Commodities, Exchange 2022-05-10 voluntarily
Circuit Second Circuit
Origin original proceeding
Jurisdiction federal question
Jury Demand Plaintiff demands jury
Demanded Amount 0
Termination Class Action Missing
Procedural Progress no court action
Nature Of Judgment no monetary award
Judgement missing
Arbitration On Termination Missing
Office 1
Filing Date 2022-05-10
Termination Date 2022-05-26
Section 0078
Status Terminated

Parties

Name MCCULLOUGH
Role Plaintiff
Name ANTARES PHARMA, INC.
Role Defendant
2202550 Securities, Commodities, Exchange 2022-05-04 voluntarily
Circuit Second Circuit
Origin original proceeding
Jurisdiction federal question
Jury Demand Plaintiff demands jury
Demanded Amount 0
Termination Class Action Missing
Procedural Progress no court action
Nature Of Judgment no monetary award
Judgement missing
Arbitration On Termination Missing
Office 1
Filing Date 2022-05-04
Termination Date 2022-05-17
Section 0078
Status Terminated

Parties

Name REDFIELD
Role Plaintiff
Name ANTARES PHARMA, INC.
Role Defendant
2203693 Securities, Commodities, Exchange 2022-05-06 voluntarily
Circuit Second Circuit
Origin original proceeding
Jurisdiction federal question
Jury Demand Plaintiff demands jury
Demanded Amount 0
Termination Class Action Missing
Procedural Progress no court action
Nature Of Judgment no monetary award
Judgement missing
Arbitration On Termination Missing
Office 1
Filing Date 2022-05-06
Termination Date 2022-05-18
Section 0078
Status Terminated

Parties

Name LAWRENCE
Role Plaintiff
Name ANTARES PHARMA, INC.
Role Defendant
2202483 Securities, Commodities, Exchange 2022-04-30 voluntarily
Circuit Second Circuit
Origin original proceeding
Jurisdiction federal question
Jury Demand Plaintiff demands jury
Demanded Amount 0
Termination Class Action Missing
Procedural Progress no court action
Nature Of Judgment no monetary award
Judgement missing
Arbitration On Termination Missing
Office 1
Filing Date 2022-04-30
Termination Date 2022-05-26
Section 0078
Status Terminated

Parties

Name BERRY
Role Plaintiff
Name ANTARES PHARMA, INC.
Role Defendant
2203550 Securities, Commodities, Exchange 2022-05-03 voluntarily
Circuit Second Circuit
Origin original proceeding
Jurisdiction federal question
Jury Demand Plaintiff demands jury
Demanded Amount 0
Termination Class Action Missing
Procedural Progress no court action
Nature Of Judgment no monetary award
Judgement missing
Arbitration On Termination Missing
Office 1
Filing Date 2022-05-03
Termination Date 2022-05-18
Section 0078
Status Terminated

Parties

Name OCHOA
Role Plaintiff
Name ANTARES PHARMA, INC.
Role Defendant
2203426 Securities, Commodities, Exchange 2022-04-27 voluntarily
Circuit Second Circuit
Origin original proceeding
Jurisdiction federal question
Jury Demand Plaintiff demands jury
Demanded Amount 0
Termination Class Action Missing
Procedural Progress no court action
Nature Of Judgment no monetary award
Judgement missing
Arbitration On Termination Missing
Office 1
Filing Date 2022-04-27
Termination Date 2022-05-18
Section 0078
Status Terminated

Parties

Name STEIN
Role Plaintiff
Name ANTARES PHARMA, INC.
Role Defendant

Date of last update: 25 Mar 2025

Sources: New York Secretary of State